• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table D2jOropharyngeal cancer, skin

StudyRec#No. PtsSettingGroup% Stage III/IVRating SystemGradeAcute %p valueLate %p valueComments
RT + CCTx
IMRT vs 3DCRT
Rusthoven, 20081320087RT + CCTxIMRT
3DCRT
100
100
CTC≥ 334
52
0.002
IMRT vs 2DRT
Lee, 20062350112RT + CCTxIMRT
2DRT
100
98.6
RTOG/EORTC3–410
14
NR
Mixed Settings
IMRT vs 3DCRT
Rades, 2007271044postop RT ± CCTxIMRT
3DCRT
≥50
≥65
Acute-CTC;
Late-RTOG
2–3~95
~90
NR~7
~12
NR
Nutting, 20094122084RT/postop ± preRT CTxIMRT
3DCRT
77 (all)CTCAE v3 (acute)
LENT SOM (late)
≥ 276
93
0.028
15
0.46
3DCRT vs 2DRT
Rades, 20072710130postop RT ± CCTx3DCRT
2DRT
≥65
≥54
Acute-CTC;
Late-RTOG
2–3~90
~93
NR~12
~14
NR
IMRT vs 2DRT
Rades, 20072710122postop RT ± CCTxIMRT
2DRT
≥50
≥54
Acute-CTC;
Late-RTOG
2–3~95
~93
NR~7
~14
NR
Chao, 200199404301º/preop/postop RT ± CCTxdefIMRT
def2DRT
postopIMRT
postop2DRT
preop2DRT
91.7
63.7
85.7
86.7
71.6
RTOG2–358.3
72.5
57.1
57.7
27.5
NR10
16.8
8.3
15.8
5.0
NR

From: Appendix D, Comparative Studies: Full Evidence/Data Abstraction Tables

Cover of Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer [Internet].
Comparative Effectiveness Reviews, No. 20.
Samson DJ, Ratko TA, Rothenberg BM, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.